Shanet Susan Alex

Shanet Susan Alex

Ph.D. Pharmacy

Shanet Susan Alex, a medical writer, based in Kerala, India, is a Doctor of Pharmacy graduate from Kerala University of Health Sciences. Her academic background is in clinical pharmacy and research, and she is passionate about medical writing. Shanet has published papers in the International Journal of Medical Science and Current Research (IJMSCR), the International Journal of Pharmacy (IJP), and the International Journal of Medical Science and Applied Research (IJMSAR). Apart from work, she enjoys listening to music and watching movies.

Articles from Shanet

Heightened antibody responses in COVID-19 booster vaccinated individuals following SARS-CoV-2 Omicron

Heightened antibody responses in COVID-19 booster vaccinated individuals following SARS-CoV-2 Omicron

Elevated and sustained autoantibodies following COVID-19

Elevated and sustained autoantibodies following COVID-19

COVID-19 booster or additional primary vaccination dose against SARS-CoV-2 Omicron in nursing home occupants

COVID-19 booster or additional primary vaccination dose against SARS-CoV-2 Omicron in nursing home occupants

The potential impact of oral vaccination against COVID-19 on transmission to naïve individuals studied in a hamster infection model

The potential impact of oral vaccination against COVID-19 on transmission to naïve individuals studied in a hamster infection model

Effectiveness of BNT162b2 third dose against Omicron-associated severe disease

Effectiveness of BNT162b2 third dose against Omicron-associated severe disease

Is type 1 diabetes likely to rise after the COVID pandemic?

Is type 1 diabetes likely to rise after the COVID pandemic?

Honeybee-based SARS-CoV-2 diagnostics

Honeybee-based SARS-CoV-2 diagnostics

miRNAs associated with varying clinical presentations of SARS-CoV-2

miRNAs associated with varying clinical presentations of SARS-CoV-2

Relevance of stem-loop 2 motif in SARS-CoV-2 and astroviruses

Relevance of stem-loop 2 motif in SARS-CoV-2 and astroviruses

SARS-CoV-2 Omicron BA.2.12.1, BA.4 and BA.5 subvariants are superior to their predecessors

SARS-CoV-2 Omicron BA.2.12.1, BA.4 and BA.5 subvariants are superior to their predecessors